Omics Technologies Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Omics Technologies Market, By Product Type

7.1. Omics Technologies Market, by Product Type

7.1.1. Sequencing Platforms (NGS & Long-read)

7.1.1.1. Market Revenue and Forecast

7.1.2. Mass Spectrometry Systems

7.1.2.1. Market Revenue and Forecast

7.1.3. Bioinformatics & Data Analysis Software

7.1.3.1. Market Revenue and Forecast

7.1.4. Sample Preparation Kits & Consumables

7.1.4.1. Market Revenue and Forecast

7.1.5. Microarrays & Hybridization Platforms

7.1.5.1. Market Revenue and Forecast

7.1.6. Reagents & Ancillaries

7.1.6.1. Market Revenue and Forecast

Chapter 8. Global Omics Technologies Market, By Omics Type

8.1. Omics Technologies Market, by Omics Type

8.1.1. Genomics

8.1.1.1. Market Revenue and Forecast

8.1.2. Transcriptomic

8.1.2.1. Market Revenue and Forecast

8.1.3. Proteomic

8.1.3.1. Market Revenue and Forecast

8.1.4. Metabolomics

8.1.4.1. Market Revenue and Forecast

8.1.5. Epigenomics

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Omics Technologies Market, By Deployment Type

9.1. Omics Technologies Market, by Deployment Type

9.1.1. On-Premises

9.1.1.1. Market Revenue and Forecast

9.1.2. Cloud-Based

9.1.2.1. Market Revenue and Forecast

9.1.3. Hybrid (On-Premises + Cloud)

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Omics Technologies Market, By Application

10.1. Omics Technologies Market, by Application

10.1.1. Drug Discovery & Development

10.1.1.1. Market Revenue and Forecast

10.1.2. Clinical Diagnostics & Precision Medicine

10.1.2.1. Market Revenue and Forecast

10.1.3. Biomarker Discovery & Validation

10.1.3.1. Market Revenue and Forecast

10.1.4. Basic & Translational Research

10.1.4.1. Market Revenue and Forecast

10.1.5. Agricultural/Environmental Omics

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Omics Technologies Market, By Technology/Mode of Action

11.1. Omics Technologies Market, by Technology/Mode of Action

11.1.1. Next-generation Sequencing (NGS)

11.1.1.1. Market Revenue and Forecast

11.1.2. Mass Spectrometry-based Technologies

11.1.2.1. Market Revenue and Forecast

11.1.3. Single cell & Spatial Omics Technologies

11.1.3.1. Market Revenue and Forecast

11.1.4. Microarray Technologies

11.1.4.1. Market Revenue and Forecast

11.1.5. Bioinformatics/AI-driven Analytics

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Omics Technologies Market, By End-User

12.1. Omics Technologies Market, by End-User

12.1.1. Academic & Research Institute

12.1.1.1. Market Revenue and Forecast

12.1.2. Pharmaceutical & Biotechnology Companies

12.1.2.1. Market Revenue and Forecast

12.1.3. Clinical Laboratories & Hospitals

12.1.3.1. Market Revenue and Forecast

12.1.4. Contract Research Organizations (CROs)

12.1.4.1. Market Revenue and Forecast

12.1.5. Agricultural/Environmental Labs

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global Omics Technologies Market, By Sample Type

13.1. Omics Technologies Market, by Sample Type

13.1.1. Tissue Samples (incl. FFPE)

13.1.1.1. Market Revenue and Forecast

13.1.2. Blood/Plasma/Serum

13.1.2.1. Market Revenue and Forecast

13.1.3. Single Cells

13.1.3.1. Market Revenue and Forecast

13.1.4. Microbial/Environmental Samples

13.1.4.1. Market Revenue and Forecast

13.1.5. FFPE (explicit)

13.1.5.1. Market Revenue and Forecast

Chapter 14. Global Omics Technologies Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product Type

14.1.2. Market Revenue and Forecast, by Omics Type

14.1.3. Market Revenue and Forecast, by Deployment Type

14.1.4. Market Revenue and Forecast, by Application

14.1.5. Market Revenue and Forecast, by Technology/Mode of Action

14.1.6. Market Revenue and Forecast, by Sample Type

14.1.7. Market Revenue and Forecast, by End-User

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Product Type

14.1.8.2. Market Revenue and Forecast, by Omics Type

14.1.8.3. Market Revenue and Forecast, by Deployment Type

14.1.8.4. Market Revenue and Forecast, by Application

14.1.8.5. Market Revenue and Forecast, by Technology/Mode of Action

14.1.8.6. Market Revenue and Forecast, by Sample Type

14.1.8.7. Market Revenue and Forecast, by End-User

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product Type

14.1.9.2. Market Revenue and Forecast, by Omics Type

14.1.9.3. Market Revenue and Forecast, by Deployment Type

14.1.9.4. Market Revenue and Forecast, by Application

14.1.9.5. Market Revenue and Forecast, by Technology/Mode of Action

14.1.9.6. Market Revenue and Forecast, by Sample Type

14.1.9.7. Market Revenue and Forecast, by End-User

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product Type

14.2.2. Market Revenue and Forecast, by Omics Type

14.2.3. Market Revenue and Forecast, by Deployment Type

14.2.4. Market Revenue and Forecast, by Application

14.2.5. Market Revenue and Forecast, by Technology/Mode of Action

14.2.6. Market Revenue and Forecast, by Sample Type

14.2.7. Market Revenue and Forecast, by End-User

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product Type

14.2.8.2. Market Revenue and Forecast, by Omics Type

14.2.8.3. Market Revenue and Forecast, by Deployment Type

14.2.8.4. Market Revenue and Forecast, by Application

14.2.8.5. Market Revenue and Forecast, by Technology/Mode of Action

14.2.8.6. Market Revenue and Forecast, by Sample Type

14.2.8.7. Market Revenue and Forecast, by End-User

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Product Type

14.2.9.2. Market Revenue and Forecast, by Omics Type

14.2.9.3. Market Revenue and Forecast, by Deployment Type

14.2.9.4. Market Revenue and Forecast, by Application

14.2.9.5. Market Revenue and Forecast, by Technology/Mode of Action

14.2.9.6. Market Revenue and Forecast, by Sample Type

14.2.9.7. Market Revenue and Forecast, by End-User

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Product Type

14.2.10.2. Market Revenue and Forecast, by Omics Type

14.2.10.3. Market Revenue and Forecast, by Deployment Type

14.2.10.4. Market Revenue and Forecast, by Application

14.2.10.5. Market Revenue and Forecast, by Technology/Mode of Action

14.2.10.6. Market Revenue and Forecast, by Sample Type

14.2.10.7. Market Revenue and Forecast, by End-User

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Product Type

14.2.11.2. Market Revenue and Forecast, by Omics Type

14.2.11.3. Market Revenue and Forecast, by Deployment Type

14.2.11.4. Market Revenue and Forecast, by Application

14.2.11.5. Market Revenue and Forecast, by Technology/Mode of Action

14.2.11.6. Market Revenue and Forecast, by Sample Type

14.2.11.7. Market Revenue and Forecast, by End-User

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product Type

14.3.2. Market Revenue and Forecast, by Omics Type

14.3.3. Market Revenue and Forecast, by Deployment Type

14.3.4. Market Revenue and Forecast, by Application

14.3.5. Market Revenue and Forecast, by Technology/Mode of Action

14.3.6. Market Revenue and Forecast, by Sample Type

14.3.7. Market Revenue and Forecast, by End-User

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Product Type

14.3.8.2. Market Revenue and Forecast, by Omics Type

14.3.8.3. Market Revenue and Forecast, by Deployment Type

14.3.8.4. Market Revenue and Forecast, by Application

14.3.8.5. Market Revenue and Forecast, by Technology/Mode of Action

14.3.8.6. Market Revenue and Forecast, by Sample Type

14.3.8.7. Market Revenue and Forecast, by End-User

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Product Type

14.3.9.2. Market Revenue and Forecast, by Omics Type

14.3.9.3. Market Revenue and Forecast, by Deployment Type

14.3.9.4. Market Revenue and Forecast, by Application

14.3.9.5. Market Revenue and Forecast, by Technology/Mode of Action

14.3.9.6. Market Revenue and Forecast, by Sample Type

14.3.9.7. Market Revenue and Forecast, by End-User

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Product Type

14.3.10.2. Market Revenue and Forecast, by Omics Type

14.3.10.3. Market Revenue and Forecast, by Deployment Type

14.3.10.4. Market Revenue and Forecast, by Application

14.3.10.5. Market Revenue and Forecast, by Technology/Mode of Action

14.3.10.6. Market Revenue and Forecast, by Sample Type

14.3.10.7. Market Revenue and Forecast, by End-User

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Product Type

14.3.11.2. Market Revenue and Forecast, by Omics Type

14.3.11.3. Market Revenue and Forecast, by Deployment Type

14.3.11.4. Market Revenue and Forecast, by Application

14.3.11.5. Market Revenue and Forecast, by Technology/Mode of Action

14.3.11.6. Market Revenue and Forecast, by Sample Type

14.3.11.7. Market Revenue and Forecast, by End-User

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product Type

14.4.2. Market Revenue and Forecast, by Omics Type

14.4.3. Market Revenue and Forecast, by Deployment Type

14.4.4. Market Revenue and Forecast, by Application

14.4.5. Market Revenue and Forecast, by Technology/Mode of Action

14.4.6. Market Revenue and Forecast, by Sample Type

14.4.7. Market Revenue and Forecast, by End-User

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Product Type

14.4.8.2. Market Revenue and Forecast, by Omics Type

14.4.8.3. Market Revenue and Forecast, by Deployment Type

14.4.8.4. Market Revenue and Forecast, by Application

14.4.8.5. Market Revenue and Forecast, by Technology/Mode of Action

14.4.8.6. Market Revenue and Forecast, by Sample Type

14.4.8.7. Market Revenue and Forecast, by End-User

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Product Type

14.4.9.2. Market Revenue and Forecast, by Omics Type

14.4.9.3. Market Revenue and Forecast, by Deployment Type

14.4.9.4. Market Revenue and Forecast, by Application

14.4.9.5. Market Revenue and Forecast, by Technology/Mode of Action

14.4.9.6. Market Revenue and Forecast, by Sample Type

14.4.9.7. Market Revenue and Forecast, by End-User

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Product Type

14.4.10.2. Market Revenue and Forecast, by Omics Type

14.4.10.3. Market Revenue and Forecast, by Deployment Type

14.4.10.4. Market Revenue and Forecast, by Application

14.4.10.5. Market Revenue and Forecast, by Technology/Mode of Action

14.4.10.6. Market Revenue and Forecast, by Sample Type

14.4.10.7. Market Revenue and Forecast, by End-User

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Product Type

14.4.11.2. Market Revenue and Forecast, by Omics Type

14.4.11.3. Market Revenue and Forecast, by Deployment Type

14.4.11.4. Market Revenue and Forecast, by Application

14.4.11.5. Market Revenue and Forecast, by Technology/Mode of Action

14.4.11.6. Market Revenue and Forecast, by Sample Type

14.4.11.7. Market Revenue and Forecast, by End-User

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product Type

14.5.2. Market Revenue and Forecast, by Omics Type

14.5.3. Market Revenue and Forecast, by Deployment Type

14.5.4. Market Revenue and Forecast, by Application

14.5.5. Market Revenue and Forecast, by Technology/Mode of Action

14.5.6. Market Revenue and Forecast, by Sample Type

14.5.7. Market Revenue and Forecast, by End-User

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Product Type

14.5.8.2. Market Revenue and Forecast, by Omics Type

14.5.8.3. Market Revenue and Forecast, by Deployment Type

14.5.8.4. Market Revenue and Forecast, by Application

14.5.8.5. Market Revenue and Forecast, by Technology/Mode of Action

14.5.8.6. Market Revenue and Forecast, by Sample Type

14.5.8.7. Market Revenue and Forecast, by End-User

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product Type

14.5.9.2. Market Revenue and Forecast, by Omics Type

14.5.9.3. Market Revenue and Forecast, by Deployment Type

14.5.9.4. Market Revenue and Forecast, by Application

14.5.9.5. Market Revenue and Forecast, by Technology/Mode of Action

14.5.9.6. Market Revenue and Forecast, by Sample Type

14.5.9.7. Market Revenue and Forecast, by End-User

Chapter 15. Company Profiles

15.1. QIAGEN

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. PerkinElmer

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Bio-Rad Laboratories

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Bruker Corporation

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Waters Corporation

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Roche Diagnostics

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Pacific Biosciences (PacBio)

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Oxford Nanopore Technologies

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Shimadzu Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Eurofins Scientific

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms